Abstract
Previous studies have reported an association between human sirtuins’ single-nucleotide polymorphisms (SNPs) and Alzheimer’s disease (AD) susceptibility in the apolipoprotein E (APOE) ε4-negative population, although the findings are inconsistent. To obtain a more precise estimation of this relationship, we conducted a meta-analysis to assess the association between the rs10410544 C/T polymorphism of SIRT2 and the risk of AD with APOE ε4 status. We searched all relevant PubMed publications and included three studies in our meta-analysis involving a total of 1,794 patients and 2,054 control subjects. Odds ratios (ORs) with 95 % confidence intervals (CIs) were employed to evaluate the association of the SIRT2 SNP with AD susceptibility, and we analyzed the extracted data stratified by the APOE ε4-carrying status. Overall, the results show that the SIRT2 SNP is associated with human AD risk in the comparison models (T vs. C: OR 1.140, 95 % CI 1.034–1.258; TC vs. CC: OR 1.178, 95 % CI 1.019–1.361; TT + TC vs. CC: OR 1.197, 95 % CI 1.043–1.373). In the stratified analyses, the European population had a significantly increased risk of AD (T vs. C: OR 1.110, 95 % CI 1.002–1.229), and we also observed a significant association in the APOE ε4-negative population (T vs. C: OR 1.165, 95 % CI 1.025–1.324; TT + TC vs. CC: OR 1.222, 95 % CI 1.022–1.461). This meta-analysis indicates that the presence of the SIRT2 SNP with APOE ε4-negative status contributes to the development of AD in humans Epidemiological studies of larger sample sizes are warranted to confirm this hypothesis.
Similar content being viewed by others
References
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011). Alzheimer’s disease. Lancet, 377(9770), 1019–1031. doi:10.1016/S0140-6736(10)61349-9.
Barker, W. W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., et al. (2002). Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Disease and Associated Disorders, 16(4), 203–212.
Bertram, L., & Tanzi, R. E. (2008). Thirty years of Alzheimer’s disease genetics: The implications of systematic meta-analyses. Nature Reviews Neuroscience, 9(10), 768–778. doi:10.1038/nrn2494.
Calnan, D. R., & Brunet, A. (2008). The FoxO code. Oncogene, 27(16), 2276–2288. doi:10.1038/onc.2008.21.
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 261(5123), 921–923.
Crean, S., Ward, A., Mercaldi, C. J., Collins, J. M., Cook, M. N., Baker, N. L., et al. (2011). Apolipoprotein E epsilon4 prevalence in Alzheimer’s disease patients varies across global populations: a systematic literature review and meta-analysis. Dementia and Geriatric Cognitive Disorders, 31(1), 20–30. doi:10.1159/000321984.
Crow, J. F. (1988). Eighty years ago: the beginnings of population genetics. Genetics, 119(3), 473–476.
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188.
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet, 366(9503), 2112–2117. doi:10.1016/S0140-6736(05)67889-0.
Frye, R. A. (2000). Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochemical and Biophysical Research Communications, 273(2), 793–798. doi:10.1006/bbrc. 2000.3000.
Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature, 349(6311), 704–706. doi:10.1038/349704a0.
Gregoire, G., Derderian, F., & Le Lorier, J. (1995). Selecting the language of the publications included in a meta-analysis: Is there a Tower of Babel bias? Journal of Clinical Epidemiology, 48(1), 159–163.
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nature Genetics, 41(10), 1088–1093. doi:10.1038/ng.440.
Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J. C., Carrasquillo, M. M., et al. (2011). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nature Genetics, 43(5), 429–435. doi:10.1038/ng.803.
Jungerius, B. J., van Laere, A. S., Te Pas, M. F., van Oost, B. A., Andersson, L., & Groenen, M. A. (2004). The IGF2-intron3-G3072A substitution explains a major imprinted QTL effect on backfat thickness in a Meishan x European white pig intercross. Genetical Research, 84(2), 95–101.
Knoll, A., Putnova, L., Dvorak, J., & Cepica, S. (2000). A NciI PCR-RFLP within intron 2 of the porcine insulin-like growth factor 2 (IGF2) gene. Animal Genetics, 31(2), 150–151.
Lambert, J. C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nature Genetics, 41(10), 1094–1099. doi:10.1038/ng.439.
Li, W., Zhang, B., Tang, J., Cao, Q., Wu, Y., Wu, C., et al. (2007). Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin. Journal of Neuroscience, 27(10), 2606–2616. doi:10.1523/JNEUROSCI.4181-06.2007.
Liu, G. L., Jiang, S. W., Xiong, Y. Z., Zheng, R., & Qu, Y. C. (2003). Association of PCR-RFLP polymorphisms of IGF2 gene with fat deposit related traits in pig resource family. Yi Chuan Xue Bao, 30(12), 1107–1112.
Mantel, N., & Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute, 22(4), 719–748.
Maxwell, M. M., Tomkinson, E. M., Nobles, J., Wizeman, J. W., Amore, A. M., Quinti, L., et al. (2011). The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Human Molecular Genetics, 20(20), 3986–3996. doi:10.1093/hmg/ddr326.
Moher, D., Fortin, P., Jadad, A. R., Juni, P., Klassen, T., Le Lorier, J., et al. (1996). Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet, 347(8998), 363–366.
Naj, A. C., Jun, G., Beecham, G. W., Wang, L. S., Vardarajan, B. N., Buros, J., et al. (2011). Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nature Genetics, 43(5), 436–441. doi:10.1038/ng.801.
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., & Verdin, E. (2003). The human Sir2 ortholog, SIRT2, is an NAD + -dependent tubulin deacetylase. Molecular Cell, 11(2), 437–444.
North, B. J., & Verdin, E. (2004). Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biology, 5(5), 224. doi:10.1186/gb-2004-5-5-224.
Polito, L., Kehoe, P. G., Davin, A., Benussi, L., Ghidoni, R., Binetti, G., et al. (2013). The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease in two Caucasian case–control cohorts. Alzheimers Dement, 9(4), 392–399. doi:10.1016/j.jalz.2012.02.003.
Polito, L., Kehoe, P. G., Forloni, G., & Albani, D. (2010). The molecular genetics of sirtuins: association with human longevity and age-related diseases. International Journal of Molecular Epidemiology and Genetics, 1(3), 214–225.
Porcelli, S., Salfi, R., Politis, A., Atti, A. R., Albani, D., Chierchia, A., et al. (2013). Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer’s disease in two independent European samples. Journal of Neural Transmission,. doi:10.1007/s00702-013-1045-6.
Serretti, A., Olgiati, P., & De Ronchi, D. (2007). Genetics of Alzheimer’s disease. A rapidly evolving field. Journal of Alzheimer’s Disease, 12(1), 73–92.
Seshadri, S., Fitzpatrick, A. L., Ikram, M. A., DeStefano, A. L., Gudnason, V., Boada, M., et al. (2010). Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA, 303(18), 1832–1840. doi:10.1001/jama.2010.574.
Sundstrom, A., Nilsson, L. G., Cruts, M., Adolfsson, R., Van Broeckhoven, C., & Nyberg, L. (2007). Increased risk of dementia following mild head injury for carriers but not for non-carriers of the APOE epsilon4 allele. International Psychogeriatrics, 19(1), 159–165. doi:10.1017/S1041610206003498.
Vaquero, A., Scher, M. B., Lee, D. H., Sutton, A., Cheng, H. L., Alt, F. W., et al. (2006). SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes and Development, 20(10), 1256–1261. doi:10.1101/gad.1412706.
Xia, M., Yu, J. T., Miao, D., Lu, R. C., Zheng, X. P., & Tan, L. (2013). SIRT2 polymorphism rs10410544 is associated with Alzheimer’s disease in a Han Chinese population. Journal of the Neurological Sciences,. doi:10.1016/j.jns.2013.10.001.
Acknowledgements
This work was supported by grants from the National High Technology Research and Development Program of China (863) (2012AA02A508), International Cooperation Program (2012DFA30470), National Natural Science Foundation of China (91229121, 81272792, 81172389, 81372709, 81302185, 81101901,81302184), Jiangsu Province’s Natural Science Foundation (BK2011847 and 20131019), Jiangsu Province’s Key Provincial Talents Program (RC2011051), Jiangsu Province’s Key Discipline of Medicine (XK201117), Jiangsu Provincial Special Program of Medical Science (BL2012028), and Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Wenjin Wei, Xiupeng Xu, and Hailin Li have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wei, W., Xu, X., Li, H. et al. The SIRT2 Polymorphism rs10410544 and Risk of Alzheimer’s Disease: A Meta-analysis. Neuromol Med 16, 448–456 (2014). https://doi.org/10.1007/s12017-014-8291-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-014-8291-0